Annovis Bio Reports Positive Results from Final Phase of $1.9M NIH Funded Chronic Toxicology Study for its Lead Compound for the Treatment of Alzheimer’s and Parkinson’s Diseases

See more here


Ossianix to Present Preclinical Data Demonstrating Best-in-Class Blood Brain Barrier Delivery in Non-Human Primates by Single Domain VNAR Antibodies

– Over 30-Fold Increase in Hippocampus Observed –

– Results Promising for Delivery of Biological Therapeutics for Neurologic Diseases –

– Results to be Presented at Protein & Antibody Engineering Summit Europe –

See more here


Aptar Pharma Acquires the Assets of Cohero Health, a Digital Respiratory Health Company, Further Expanding its Capabilities in Digital Health

See more here


Mebias Discovery Receives Grant from NIDA to Advance MEB‑1170 as an Analgesic Drug Candidate for the Prevention and Treatment of Opioid Use Disorder 
Grant to Fund IND Enabling and Phase 1 Clinical Trials

Preclinical Data Demonstrates MEB‑1170 Lacks Dangerous Side Effects Including Respiratory Depression and Opioid Abuse Potential

See more here


Annovis Bio Resumes Treatment of Patients in Ongoing Phase 2a Study in Alzheimer’s Disease After COVID-Related Delay

See more here


Relmada Therapeutics Expands R&D Team, Appoints Paolo Manfredi, M.D., as Acting Chief Scientific Officer, Marco Pappagallo, M.D., as Acting Chief Medical Officer and Updates R&D Milestones 

See more here


Envara Health Launches Encala® to Enhance Fat Absorption and Provide Healthy Calories for Patients with Cystic Fibrosis
New, innovative therapy brings breakthrough science and clinical evidence to nutrition

Helps patients with malabsorption meet their weight and nutritional needs   

See more here


Halo Labs Announces New Products and Leadership Changes
Dr. Joseph Keegan, Executive Chairman, to Assume Interim Leadership 

See more here


Immunome Announces Exercise in Full and Closing of Over-Allotment Option in Initial Public Offering

See more here